Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

by Sofia Fund | Aug 9, 2022 | Portfolio Company News

Cognition Therapeutics reported on 2^nd quarter financial results and business updates including optimistic advancements in clinical trials.

Click here to read the full press release.

Older post: Cognition Therapeutics Presents New Proteomic Data on Effect of CT1812 Treatment on Normalization of Disrupted Alzheimer’s Disease Processes

Newer post: Women Investment Pioneer Joy Lindsay Named 2023 Entrepreneur of the Year by University of Minnesota